The sixth geriatric oncology professional committee of the annual conference of the sixth Chinese Geriatric Oncology Conference, in April 2012 20 to 22 in Beijing Jiuhua is held ceremoniously. Nearly a thousand experts and scholars from abroad and at home and abroad have gathered in one of the experts and scholars.

Since its establishment in November 2006, CGOS has been developing rapidly in a few short years, showing a strong cohesion and appeal. The conference papers related to the elderly, clinical, traditional Chinese medicine and Western medicine and other related professional. The meeting group specially organized experts to contribute papers were selected, and selected 10 outstanding papers.

The current annual meeting, in addition to continue to employ well-known domestic and foreign oncology experts, the latest information on elderly cancer in various areas of expertise exchange and discuss, but also is divided into a plurality of branch field, covering almost all relevant fields of elderly cancer: gastrointestinal cancer and palliative analgesic, green CGOS- salon, lung cancer, breast cancer, and vascular target to the six special, but also pay attention to the balance of traditional Chinese medicine and Western medicine, young and old treatment difference.

On the afternoon of April 21 by Bai Li, Xu Jianming experts under the auspices of the digestive tract of the special paper in the report from medical oncology hospital in accordance with the Hebali and later the doctor is "randomized, Single-centered phase II clinical trial of nimotuzumab plus cisplatin and S-1 as 1st line therapy in patients with advanced gastric cancer" of key report.